Therapeutic selectivity and risk/benefit assessment of hypolipidemic drugs

Therapeutic selectivity and risk/benefit assessment of hypolipidemic drugs
Details
- OL Work ID
- OL19154987W
Subjects
HyperlipidemiaAntilipemic agentsDrug therapySide effectsChemotherapyTherapeutic useTestingHyperlipemiaHypolipidemic AgentsHyperlipidemias